サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1448051

動物用寄生虫駆除剤市場-2023年～2030年

Animal Parasiticides Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 210 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
動物用寄生虫駆除剤市場-2023年～2030年
出版日: 2024年03月08日
発行: DataM Intelligence
ページ情報: 英文 210 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

動物用寄生虫駆除剤の世界市場は、2022年に118億米ドルに達し、2030年には190億9,000万米ドルに達すると予測され、予測期間2023-2030年のCAGRは6.2%で成長する見込みです。

動物用寄生虫駆除剤は、動物の寄生虫を予防、制御、駆除するもので、動物の健康状態を最適に維持し、成長率や繁殖能力の向上につながる可能性があるため、世界の動物用寄生虫駆除剤市場は長年にわたって大きな成長と変貌を遂げてきました。

さらに、製造企業はこれらの製品に投資しており、例えば2023年10月には、ヒトと動物の健康における世界的リーダーであるベーリンガーインゲルハイムが、インドでNexGard（afoxolaner）S and Mを発売しました。これは生後8週齢からの犬や子犬に使用でき、嗜好性の高い風味のチュアブル剤で月1回投与され、ノミが卵を産む前に駆除し、マダニやダニも駆除します。

外部寄生虫駆除剤セグメントは世界市場で最大のシェアを占めているが、アジア太平洋地域も同様に世界市場で圧倒的なシェアを示しています。アジア太平洋地域では食肉消費需要が高く、オーストラリアでは毎日約50.1kgの鶏肉が消費されています。オーストラリアでは毎日約50.1kgの鶏肉が消費されており、これが動物用寄生虫駆除剤の世界市場を牽引しています。

市場力学

動物疾病の有病率の増加

例えば、2023年2月にTimes of Hinduに掲載されたレポートによると、高知の獣医病院ではここ数週間、毎日5～6件の犬のダニ熱症例が目撃されています。したがって、このようなマダニ症例の増加は、世界の動物用寄生虫駆除剤市場の牽引役となる可能性があります。

さらに、動物の疾病の蔓延が増加しているため、これらの疾病の蔓延を防止し、動物の健康と幸福を守るのに役立つ寄生虫駆除剤が消費者に高く支持されています。そのため、寄生虫駆除剤の認知度は市場の成長拡大に寄与しています。

ペット飼育率の上昇

例えば、KC Campus for Animal Careを運営する慈善団体KC Pet Projectによると、2022年には犬4,661匹、猫5,904匹、その他160匹を含む約10,725匹のペットが採用されました。したがって、このようなペットの養子縁組の高い率は、市場の成長を後押しするのに役立ちます。

さらに、ペットの飼育率が高まるにつれて、ノミ、ダニ、回虫などさまざまな寄生虫の予防や治療に役立つ寄生虫駆除剤など、これらの動物の健康と福祉を確保する製品への需要が高まっています。したがって、このような要因は、幅広い動物に対する寄生虫駆除剤の採用率を拡大することに貢献する可能性があります。

耐性菌の発生

動物用寄生虫駆除剤市場にとって、耐性菌開発は重要な課題です。寄生虫は時間の経過とともに、特定の種類の寄生虫駆除剤に対する耐性を獲得する可能性があります。このような感受性の低下により、これらの薬剤の効率が低下する可能性があり、動物の寄生虫蔓延の管理と根絶がより困難になります。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 動物疾病の増加
      • ペット飼育率の上昇
    • 抑制要因
      • 耐性菌の発生
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 生産分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品別

  • 外部寄生虫駆除剤
    • プッシュオン
    • スポットオン
    • スプレー
    • 粉剤
    • その他
  • 寄生虫駆除剤
    • 注射剤
    • 経口液剤
    • 経口錠剤
    • 飼料添加物
  • 駆虫剤
  • その他

第8章 寄生虫タイプ別

  • 回虫
  • 条虫
  • 心虫
  • フラムシ
  • コクシジウム
  • ダニ
  • マダニ
  • ノミ
  • シラミ
  • ウジ虫の侵入
  • その他

第9章 流通チャネル別

  • eコマース
  • 動物病院・クリニック
  • 薬局
  • その他

第10章 製品形態別

  • カプセル／錠剤
  • 粉末
  • 液体
  • 軟膏
  • その他

第11章 動物タイプ別

  • 牛
  • 愛玩動物
  • 家畜

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • Zoetis Services LLC.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Elanco
  • Virbac
  • Boehringer Ingelheim International GmbH.
  • Merck & Co., Inc.
  • Vetoquinol
  • PetIQ, LLC.
  • ECO-Animal Health Ltd.
  • Norbrook
  • Ceva

第15章 付録

目次
Product Code: AG8098

Overview

Global Animal parasiticides market reached US$ 11.8 billion in 2022 and is expected to reach US$ 19.09 billion by 2030, growing with a CAGR of 6.2% during the forecast period 2023-2030.

The global animal parasiticides market has witnessed significant growth and transformations over the years, as they are designed to prevent, control, or eliminate parasites in animals, and help in maintaining optimal health conditions for animals, potentially leading to improved growth rates, and reproductive performance.

Furthermore, manufacturing companies are investing in these products, for instance, in October 2023, Boehringer Ingelheim, a global leader in human and animal health launched NexGard (afoxolaner) S and M in India. This is suitable for use in dogs and puppies from eight weeks of age and is delivered as a monthly treatment in highly palatable flavored chewables that kill fleas before they can lay eggs, ticks, and mites.

The ectoparasiticides segment accounts for the largest share in the global market, similarly Asia- the Asia-Pacific region shows a dominant world share, as the demand for meat consumption is high in this region, in Australia around 50.1 kg of chicken meat is consumed every day. It can help in driving the global animal parasiticides market.

Dynamics

Increase in Prevalence of Animal Diseases

Over the past few years, the prevalence of animal diseases has increased, for instance, according to the report published in the Times of Hindu in February 2023, Kochi Vet hospitals have been witnessing five to six tick fever cases in dogs daily over the past few weeks. Hence, such instances of increase in tick cases can help in driving the global animal parasiticides market.

Furthermore, as the prevalence of animal diseases is increasing, consumers are highly adopting these parasiticides as they help prevent the spread of these diseases, protecting the health and well-being of the animals. Hence, the awareness of the parasiticides products can contribute to increasing the market growth.

Rising Pet Adoption Rate

people around the world are choosing to adopt pets, for instance, according to KC Pet Project, a charitable organization operating the KC Campus for Animal Care report, around 10,725 pets were adopted in 2022 which includes 4,661 dogs, 5,904 cats, and 160 other pets. Therefore, such a high rate of pet adoptions can help in boosting the market growth.

Furthermore, as the adoption rate is increasing, it increasing the demand for products that ensure the health and well-being of these animals, including parasiticides, as they help in preventing, and treating various parasites, including fleas, ticks, and worms. Hence, such factors can contribute to expanding the adoption rate for parasiticide products for a wide range of animals.

Resistance Development

Resistance development is indeed a significant challenge for the animal parasiticides market. Parasites can develop resistance to particular types of parasiticides over time. The efficiency of these medications might decrease as a result of this lowered susceptibility, making it more difficult to manage and eradicate parasite infestations in animals.

Segment Analysis

The global animal parasiticides market is segmented based on product, parasite type, distribution channel, product form, animal type, and region.

Increase in Demand for Effective Animal Treatment

The ectoparasiticides type shows the dominance in global animal parasiticides market, consumers are highly adopting these designed to control and eliminate external parasites that infest the skin, fur, and feathers, they are highly effective in controlling, preventing, and transmitting fleas and ticks, and other infestations in pets and livestock, it can help in gaining the popularity for animal parasiticides products.

Furthermore, as the demand for these types of products is increasing, manufacturers are launching innovative products to attract larger consumer bases, for instance, in April 2023, Carus Laboratories, a leading animal health company, launched a AmitHit, a ectoparasiticide dip concentrate liquid, AmitHit is a powerful combination of an active ingredient, Amitraz and Deltamethrin which is designed to effectively kill ticks and mites in animals. Therefore, such product developments can propel the adoption rate for the animal parasiticides market.

Geographical Penetration

High Meat Consumption Rate in Asia-Pacific

Asia-Pacific has been a dominant force in the global animal parasiticides market. As the demand for meat consumption is high in this region, the livestock industries are highly adopting these parasiticides as a small animal medicine to prevent and treat for various parasites, including fleas, ticks, and worms. Also, helps in increasing the productivity of animals.

Furthermore, the meat consumption rate is high in this region, for instance, in the Australian Bureau of Agricultural and Resource Economics and Sciences. Nearly 70 percent of Australian households serve chicken meat at least twice weekly. In 2022/23 Australians they increased consumption to 50.1 kg of chicken meat on average each.

Competitive Landscape

The major global players in the market include Zoetis Services LLC., Elanco, Virbac, Boehringer Ingelheim International GmbH., Merck & Co., Inc., Vetoquinol, PetIQ, LLC., ECO - Animal Health Ltd., Norbrook, and Ceva

COVID-19 Impact Analysis

During the pandemic, the pet adoption rate has increased which has shown a positive impact on the global animal parasiticides market, but due to government lockdown restrictions, the supply chain of products has been disrupted which caused a slight declination in global animal parasiticides market.

By Product

  • Ectoparasiticides
  • Pour On
  • Spot On
  • Sprays
  • Powders
  • Others
  • Endoparasiticides
  • Injectables
  • Oral Liquids
  • Oral Tablets
  • Feed Additives
  • Endectocides
  • Others

By Parasite Type

  • Roundworms
  • Tapeworms
  • Heartworms
  • Flukes
  • Coccidia
  • Mite
  • Tick
  • Flea
  • Lice
  • Grub Infestation
  • Others

By Distribution Channel

  • E-Commerce
  • Veterinary Hospitals & Clinics
  • Pharmacies
  • Others

By Product Form

  • Capsules/Tablets
  • Powder
  • Liquid
  • Ointment
  • Others

By Animal Type

  • Cattle
  • Pet Animals
  • Livestock

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In November 2023, NOAH has launched its 'Paws to Protect' campaign to improve pet owner awareness of the importance of reading and following the warnings and recommendations on the packaging and labeling provided with veterinary medicines.
  • In May 2020, Merck Animal Health, known as MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, and Virbac acquired Merck Animal Health the U.S. rights to sentinel flavor tabs and sentinel spectrum Chews in the Companion Animal category.
  • In January 2021, Boehringer Ingelheim announced that it has received marketing authorization from the EMA (European Medicine Agency) and European Commission for its NexGard COMBO topical solution for cats. This innovative parasiticide will be available in the European Union shortly. NexGard COMBO offers unparalleled protection for cats.

Why Purchase the Report?

  • To visualize the global animal parasiticides market segmentation based on product, parasite type, distribution channel, product form, animal type and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of animal parasiticides market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global animal parasiticides market report would provide approximately 78 tables, 84 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Product
  • 3.2.Snippet by Parasite Type
  • 3.3.Snippet by Distribution Channel
  • 3.4.Snippet by Product Form
  • 3.5.Snippet by Animal Type
  • 3.6.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increase in Prevalence of Animal Diseases
      • 4.1.1.2.Rising Pet Adoption Rate
    • 4.1.2.Restraints
      • 4.1.2.1.Resistance development
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Production Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Product

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2.Market Attractiveness Index, By Product
  • 7.2.Ectoparasiticides*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3.Pour On
    • 7.2.4.Spot On
    • 7.2.5.Sprays
    • 7.2.6.Powders
    • 7.2.7.Others
  • 7.3.Endoparasiticides
    • 7.3.1.Injectables
    • 7.3.2.Oral Liquids
    • 7.3.3.Oral Tablets
    • 7.3.4.Feed Additives
  • 7.4.Endectocides
  • 7.5.Others

8.By Parasite Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Parasite Type
    • 8.1.2.Market Attractiveness Index, By Parasite Type
  • 8.2.Roundworms*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Tapeworms
  • 8.4.Heartworms
  • 8.5.Flukes
  • 8.6.Coccidia
  • 8.7.Mite
  • 8.8.Tick
  • 8.9.Flea
  • 8.10.Lice
  • 8.11.Grub Infestation
  • 8.12.Others

9.By Distribution Channel

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2.Market Attractiveness Index, By Distribution Channel
  • 9.2.E-Commerce*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Veterinary Hospitals & Clinics
  • 9.4.Pharmacies
  • 9.5.Others

10.By Product Form

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 10.1.2.Market Attractiveness Index, By Product Form
  • 10.2.Capsules/Tablets*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Powder
  • 10.4.Liquid
  • 10.5.Ointment
  • 10.6.Others

11.By Animal Type

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 11.1.2.Market Attractiveness Index, By Animal Type
  • 11.2.Cattle*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Pet Animals
  • 11.4.Livestock

12.By Region

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2.Market Attractiveness Index, By Region
  • 12.2.North America
    • 12.2.1.Introduction
    • 12.2.2.Key Region-Specific Dynamics
    • 12.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Parasite Type
    • 12.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 12.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 12.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1.U.S.
      • 12.2.8.2.Canada
      • 12.2.8.3.Mexico
  • 12.3.Europe
    • 12.3.1.Introduction
    • 12.3.2.Key Region-Specific Dynamics
    • 12.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Parasite Type
    • 12.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 12.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 12.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1.Germany
      • 12.3.8.2.UK
      • 12.3.8.3.France
      • 12.3.8.4.Italy
      • 12.3.8.5.Russia
      • 12.3.8.6.Rest of Europe
  • 12.4.South America
    • 12.4.1.Introduction
    • 12.4.2.Key Region-Specific Dynamics
    • 12.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Parasite Type
    • 12.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 12.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 12.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1.Brazil
      • 12.4.8.2.Argentina
      • 12.4.8.3.Rest of South America
  • 12.5.Asia-Pacific
    • 12.5.1.Introduction
    • 12.5.2.Key Region-Specific Dynamics
    • 12.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Parasite Type
    • 12.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 12.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 12.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1.China
      • 12.5.8.2.India
      • 12.5.8.3.Japan
      • 12.5.8.4.Australia
      • 12.5.8.5.Rest of Asia-Pacific
  • 12.6.Middle East and Africa
    • 12.6.1.Introduction
    • 12.6.2.Key Region-Specific Dynamics
    • 12.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Parasite Type
    • 12.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Form
    • 12.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type

13.Competitive Landscape

  • 13.1.Competitive Scenario
  • 13.2.Market Positioning/Share Analysis
  • 13.3.Mergers and Acquisitions Analysis

14.Company Profiles

  • 14.1. Zoetis Services LLC. *
    • 14.1.1.Company Overview
    • 14.1.2.Product Portfolio and Description
    • 14.1.3.Financial Overview
    • 14.1.4.Key Developments
  • 14.2.Elanco
  • 14.3.Virbac
  • 14.4.Boehringer Ingelheim International GmbH.
  • 14.5.Merck & Co., Inc.
  • 14.6.Vetoquinol
  • 14.7.PetIQ, LLC.
  • 14.8.ECO - Animal Health Ltd.
  • 14.9.Norbrook
  • 14.10.Ceva

LIST NOT EXHAUSTIVE

15.Appendix

  • 15.1.About Us and Services
  • 15.2.Contact Us